Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study - Ahmadzadehfar, H; Rahbar, K; Kürpig, S (EJNMMI research, 2015)
et al.